ELI: http://data.europa.eu/eli/reg_impl/2024/859/oj 1/3COMMISSION IMPLEMENTING REGUL ATION (EU) 2024/859 
of 18 March 2024
amending Regulation (EU) No 37/2010 as regards the classif ication of the subst ance sodium salicylate 
with respect to its maximum residue limit in foods tuffs of animal origin 
(Text with EEA relevance) 
THE EUR OPEAN COMMISSION,
Havi ng regar d to the Treaty on the Functioning of the European Union,
Havi ng regar d to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down 
Community procedures for the establishment of residue limits of phar macologically active substances in foodstuffs of 
animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European 
Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (1), and in 
particular Article 14, in conjunction with Article 17, thereof,
Whereas:
(1) Table 1 of the Annex to Commission Regulation (EU) No 37/2010 (2)sets out the phar macologically active 
substances and their classification regar ding maximum residue limits (‘MRLs ’) in foodstuffs of animal origin.
(2) The substance sodium salicylate is included in that table as an allowe d substance.
(3) On 30 September 2022 , pursuant to Article 3 of Regulation (EC) No 470/2009, Dophar ma B.V. submitted an 
application to the European Medicines Age ncy (‘Agen cy’) for the exte nsion of the existing entr y for the substance 
sodium salicylate to chicken.
(4) On 5 Octobe r 2023 , the Agen cy, based on the opinion of the Committ ee for Veterinar y Medicinal Products, set up 
pursuant to Article 139 of Regulation (EU) 2019/6 of the European Parliament and of the Council (3), and having 
considered the application of Dophar ma B.V., recommended the extensi on of maximum residue limits for the 
substance sodium salicylate in chic ken and the establishment of numer ical MRLs.
(5) The Age ncy also concluded that the extrapolation of the MRLs for sodium salicylate from chic ken tissues to the 
tissues of other poultr y species other than turk ey is appropr iate.
(6) In view of the opinion of the Agency , the Commission considers it appropr iate to establish the recommended MRL 
for sodium salicylate in chick en tissues and to extrapolate it to other poultr y species other than turke y, but 
restr icted to animals not producing eggs for human consum ption as no residue data were provid ed for eggs.
(7) Regulation (EU) No 37/2010 should theref ore be amended according ly.
(8) The measures provid ed for in this Regulation are in accordance with the opinion of the Standing Committ ee on 
Veterinar y Medicinal Products,
(1)OJ L 152, 16.6.2009, p. 11.
(2)Commission Regulation (EU) No 37/2010 of 22 December 2009 on phar macologically active substances and their classif ication 
regar ding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1).
(3)Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinar y medicinal products and 
repealing Directive 2001/82/EC (OJ L 4, 7.1.2019, p. 43).
Offi cial Jour nal  
of the European Union EN 
L series    
2024/859  19.3.2024ELI: http://data.europa.eu/eli/reg_im pl/2024/859/oj 2/3HAS ADOPTED THIS REGUL ATION:
Article 1
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Article 2
This Regulation shall enter into force on the twentieth day followi ng that of its publication in the Official Journal of the 
European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 18 Marc h 2024 .
For the Commission
The President
Ursula VON DER LEYENOJ L, 19.3.2024 EN  ELI: http://data.europa.eu/eli/reg_impl/2024/859/oj 3/3ANNEX 
In Table 1 of the Annex to Regulation (EU) No 37/2010, the entr y for the phar macologically active substance ‘sodium salicylat e’ is replaced by the followi ng:
Phar macologically active 
SubstanceMarker residue Animal Species MRL Target TissuesOther Provisions
(according to Article 14(7) 
of Regulation (EC) 
No 470/2009)Therapeutic Classif ication
‘Sodium salicylate NOT APPLICABLE Bovin e, Porcine No MRL required NOT APPLICABLE For oral use.
Not for use in animals 
from whic h milk is 
produced for human 
consump tion.NO ENTR Y
All food producing 
species excep t fin fishNo MRL required For topi cal use only .
Salicylic acid Turkey 400 μg/kg
2 500 μg/kg
200 μg/kg
150 μg/kgMuscle
Skin and fat in natural 
propor tions
Liver
KidneyNot for use in animals 
producing eggs for 
human consum ption.Anti-inf lammatory 
agents / Non-steroidal 
anti-inf lammat ory 
agents’.
Poultr y other than turk ey250 μg/kg
250 μg/kg
500 μg/kg
1 000 μg/kgMuscle
Skin and fat in natural 
propor tions
Liver
KidneyOJ L, 19.3.2024 EN